Correspondence  |   August 2016
In Reply
Author Notes
  • Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts (K.C.N.). knanji@partners.org
  • (Accepted for publication April 20, 2016.)
    (Accepted for publication April 20, 2016.)×
Article Information
Correspondence
Correspondence   |   August 2016
In Reply
Anesthesiology 8 2016, Vol.125, 432-437. doi:10.1097/ALN.0000000000001188
Anesthesiology 8 2016, Vol.125, 432-437. doi:10.1097/ALN.0000000000001188
We appreciate the opportunity to respond to the questions raised by Bowdle et al., Ibinson et al., and Chan et al. about our manuscript regarding perioperative medication errors (MEs) and adverse drug events (ADEs).1  Our goal was to assess the rates of perioperative MEs and ADEs as percentages of medication administrations, to evaluate their root causes, and to suggest targeted solutions that may have potential to prevent them. We used an observational methodology, combined with a retrospective chart review and subspecialist consultation by an independent adjudication committee, to provide additional clinical context for confirming and classifying the MEs and ADEs. We found that 5.3% of medication administrations resulted in an ME and/or an ADE, and we classified each of these by whether they involved an ME with ADE (preventable ADE), ME with potential ADE (near miss), ME with little potential for harm, or ADE without ME (nonpreventable ADE).
First Page Preview
First page PDF preview
First page PDF preview ×
View Large